
LVIS Corp Set to Revolutionize Epilepsy Diagnosis and Treatment with Launch of FDA Approved NeuroMatch Elite
PALO ALTO, CALIFORNIA, June 3, 2025 – LVIS Corp, a global leader in neurological technology, proudly announces the upcoming U.S. release of NeuroMatch Elite, a major breakthrough set to revolutionize








